Skip to main content

Table 2 Distribution of anti-L1FG/HPV16 IgG and IgA antibodies

From: Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women

 

HPV DNA

Systemic IgG

Systemic IgA

Cervical IgG

Cervical sIgA

n/total (%)

P value

n/total (%)

P value

n/total (%)

P value

n/total (%)

P value

n/total (%)

P value

General population*

14/85 (16)

 

10/85 (12)

 

5/85 (6)

 

1/85 (1)

 

3/85 (3)

 

Sex workers

20/51 (39)

0.005

13/51 (25)

0.002

12/51 (23)

0.002

8/51 (16)

0.001

4/51 (8)

0.2

LGSIL

10/16 (62)

0.0004

7/16 (44)

0.001

3/16 (19)

0.1

2/62 (12)

0.006

1/62 (5)

0.5

HGSIL

22/27 (81)

< 0.0001

4/27 (15)

0.4

4/27 (15)

0.1

0/27 (0)

0.7

0/27 (0)

0.4

  1. LGSIL low grade squamous intraepithelial lesions, HGSIL high grade squamous intraepithelial lesions
  2. * Reference group